Selective immunosuppressants
Sub categories/Drugs:
- L04AA02: muromonab-CD3
- L04AA03: antilymphocyte immunoglobulin (horse)
- L04AA04: antithymocyte immunoglobulin (rabbit)
- L04AA06: mycophenolic acid
- L04AA10: sirolimus
- L04AA13: leflunomide
- L04AA15: alefacept
- L04AA18: everolimus
- L04AA19: gusperimus
- L04AA21: efalizumab
- L04AA22: abetimus
- L04AA23: natalizumab
- L04AA24: abatacept
- L04AA25: eculizumab
- L04AA26: belimumab
- L04AA27: fingolimod
- L04AA28: belatacept
- L04AA29: tofacitinib
- L04AA31: teriflunomide
- L04AA32: apremilast
- L04AA33: vedolizumab
- L04AA34: alemtuzumab
- L04AA57: ublituximab
- L04AA58: efgartigimod alfa
- L04AA59: avacopan
Description:
Clinical Syndromes:
Morphological Classes:
References:
NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Selective immunosuppressants/adverse effects"[Mesh] OR "Selective immunosuppressants/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])
loading references for 'Selective immunosuppressants' from pubmed ...
Case Reports: